Cost-effectiveness of colorectal cancer screening programmes using sigmoidoscopy and immunochemical faecal occult blood test
Objective Several European countries are implementing organized colorectal cancer (CRC)
screening programmes using faecal immunochemical test (FIT) and/or flexible …
screening programmes using faecal immunochemical test (FIT) and/or flexible …
Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and …
L Sharp, L Tilson, S Whyte, A O'Ceilleachair… - British journal of …, 2012 - nature.com
Background: Several colorectal cancer-screening tests are available, but it is uncertain
which provides the best balance of risks and benefits within a screening programme. We …
which provides the best balance of risks and benefits within a screening programme. We …
Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy
L Hol, V de Jonge, ME Van Leerdam… - European journal of …, 2010 - Elsevier
BACKGROUND: Perceived burden of colorectal cancer (CRC) screening is an important
determinant of participation in subsequent screening rounds and therefore crucial for the …
determinant of participation in subsequent screening rounds and therefore crucial for the …
Cost-effectiveness analysis of alternative colon cancer screening strategies in the context of the French national screening program
S Barré, H Leleu, R Benamouzig… - Therapeutic …, 2020 - journals.sagepub.com
Background: A nationwide colorectal cancer (CRC) screening program was set up in France
from 2009 for average-risk, asymptomatic people aged 50–74 years based on an …
from 2009 for average-risk, asymptomatic people aged 50–74 years based on an …
Cost-effectiveness of high-sensitivity faecal immunochemical test and colonoscopy screening for colorectal cancer
M Aronsson, P Carlsson, LÅ Levin… - Journal of British …, 2017 - academic.oup.com
Background Colorectal cancer screening can decrease morbidity and mortality. However,
there are widespread differences in the implementation of programmes and choice of …
there are widespread differences in the implementation of programmes and choice of …
Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening
N Segnan, C Senore, B Andreoni, A Azzoni, L Bisanti… - Gastroenterology, 2007 - Elsevier
Background & Aims: We conducted a study to estimate population coverage and detection
rate (DR) achievable through different strategies of colorectal cancer (CRC) screening …
rate (DR) achievable through different strategies of colorectal cancer (CRC) screening …
Cost-effectiveness analysis of alternative colorectal cancer screening strategies in high-risk individuals
R Benamouzig, S Barré, JC Saurin… - Therapeutic …, 2021 - journals.sagepub.com
Background and aims: Current guidelines recommend colonoscopy every 3–5 years for
colorectal cancer (CRC) screening of individuals with a familial history of CRC. The …
colorectal cancer (CRC) screening of individuals with a familial history of CRC. The …
[HTML][HTML] What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
L van Dam, IJ Korfage, EJ Kuipers, L Hol… - European Journal of …, 2013 - Elsevier
INTRODUCTION: Uptake is an important determinant of the effectiveness of population-
based screening. Uptake of colorectal cancer (CRC) screening generally remains sub …
based screening. Uptake of colorectal cancer (CRC) screening generally remains sub …
Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy
BACKGROUND: Colorectal cancer is a major cause of mortality. This gives high public
health priority to mass screening using a noninvasive, fecal occult blood test of …
health priority to mass screening using a noninvasive, fecal occult blood test of …
Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
I Stegeman, TR de Wijkerslooth, RC Mallant-Hent… - BMC …, 2012 - Springer
Background Colorectal cancer (CRC) is the most common cancer in Europe with a mortality
rate of almost 50%. The prognosis of patients is largely determined by the clinical and …
rate of almost 50%. The prognosis of patients is largely determined by the clinical and …